Nitrofurantoin Monohydrate/ Macrocrystalline recalls
Nitrofurantoin Monohydrate/ Macrocrystalline products have been recalled 2 times, most recently on 21 Aug 2019. The recalling company is usually Alvogen. The most common reason is potency & assay.
Total recalls2since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 21 Aug 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why nitrofurantoin monohydrate/ macrocrystalline is recalled
Companies
Product types
By year
All nitrofurantoin monohydrate/ macrocrystalline recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Nitrofurantoin Monohydrate/Macrycrystals Capsules, 100 mg recalledNitrofurantoin Monohydrate/ Macrocrystalline | Alvogen | Potency & Assay | PR |
| Drug | CLASS II | Nitrofurantoin Monohydrate/Macrocrystals Capsules, 100 mg recalledNitrofurantoin Monohydrate/ Macrocrystalline | Alvogen | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.